日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy

临床相关放射性核素对IFN1反应激活的影响与放射性核素半衰期和线性能量转移相关,并影响放射性药物的抗肿瘤疗效。

Caroline P Kerr ,Julia Sheehan-Klenk ,Joseph J Grudzinski ,David P Adam ,Thanh Phuong T Nguyen ,Carolina A Ferreira ,Amber M Bates ,Won Jong Jin ,Ohyun Kwon ,Aeli P Olson ,Wilson Lin ,Meredith Hyun ,Justin C Jagodinsky ,Maria Powers ,Raghava N Sriramaneni ,Paul A Clark ,Amanda G Shea ,Hansel Comas Rojas ,Cynthia Choi ,Christopher F Massey ,Luke M Zangl ,Anatoly N Pinchuk ,Eduardo Aluicio-Sarduy ,KyungMann Kim ,Jonathan W Engle ,Reinier Hernandez ,Bryan P Bednarz ,Jamey P Weichert ,Zachary S Morris

Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library

通过新一代测序增强挖掘新型免疫 VNAR 库发现 FAP 靶向治疗诊断的开发

Gihan S Gunaratne, Joseph P Gallant, Kendahl L Ott, Payson L Broome, Sasha Celada, Jayden L West, Jason C Mixdorf, Eduardo Aluicio-Sarduy, Jonathan W Engle, Eszter Boros, Labros Meimetis, Joshua M Lang, Shuang G Zhao, Reinier Hernandez, David Kosoff, Aaron M LeBeau

Preclinical development of novel PD-L1 tracers and first-in-human study of [68Ga]Ga-NOTA-RW102 in patients with lung cancers

新型 PD-L1 示踪剂的临床前开发及 [68Ga]Ga-NOTA-RW102 在肺癌患者中的首次人体研究

You Zhang #, Min Cao #, Yanfei Wu #, Sara Malih, Dong Xu, Erpeng Yang, Muhsin H Younis, Wilson Lin, Haitao Zhao, Cheng Wang, Qiufang Liu, Jonathan W Engle, Mohammad J Rasaee, Yihui Guan, Gang Huang, Jianjun Liu, Weibo Cai, Fang Xie, Weijun Wei

Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab

利用 64Cu 标记的度伐利尤单抗进行肿瘤 PD-L1 表达的非侵入性 PET 成像

Sara Malih ,Wilson Lin ,Zhongmin Tang ,Molly C DeLuca ,Jonathan W Engle ,Behrouz Alirezapour ,Weibo Cai ,Mohammad J Rasaee

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

TROP-2在耐药性前列腺癌中的表达及治疗靶向

Jamie M Sperger # ,Kyle T Helzer # ,Charlotte N Stahlfeld # ,Dawei Jiang ,Anupama Singh ,Katherine R Kaufmann ,David J Niles ,Erika Heninger ,Nicholas R Rydzewski ,Liguo Wang ,Liewei Wang ,Rendong Yang ,Yanan Ren ,Jonathan W Engle ,Peng Huang ,Christos E Kyriakopoulos ,Susan F Slovin ,Howard R Soule ,Shuang G Zhao ,Manish Kohli ,Scott T Tagawa ,Weibo Cai ,Scott M Dehm ,Joshua M Lang

Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer

多模态成像显示聚乙二醇化 FUD 肽在乳腺癌中的肿瘤暴露增强

Hye Jin Lee, Metti K Gari, David R Inman, Zachary T Rosenkrans, Brian M Burkel, Aeli P Olson, Jonathan W Engle, Reinier Hernandez, Suzanne M Ponik, Glen S Kwon

Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

在小鼠前列腺肿瘤中,90Y-NM600靶向放射性核素疗法和PD-1阻断疗法的抗肿瘤疗效受到调节性T细胞的限制。

Hemanth K Potluri ,Carolina A Ferreira ,Joseph Grudzinski ,Christopher Massey ,Eduardo Aluicio-Sarduy ,Jonathan W Engle ,Ohyun Kwon ,Ian R Marsh ,Bryan P Bednarz ,Reinier Hernandez ,Jamey P Weichert ,Douglas G McNeel

64Cu-labeled daratumumab F(ab')2 fragment enables early visualization of CD38-positive lymphoma

64Cu 标记的达雷木单抗 F(ab')2 片段可实现 CD38 阳性淋巴瘤的早期可视化

Lei Kang, Cuicui Li, Qi Yang, Logan Sutherlin, Lin Wang, Zhao Chen, Kaelyn V Becker, Nan Huo, Yongkang Qiu, Jonathan W Engle, Rongfu Wang, Chengzhi He, Dawei Jiang, Xiaojie Xu, Weibo Cai1

ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer

胰腺癌滋养层细胞表面抗原 2 (Trop-2) 表达的免疫 PET

Weiyu Chen #, Miao Li #, Muhsin H Younis, Todd E Barnhart, Dawei Jiang, Tuanwei Sun, Joshua M Lang, Jonathan W Engle, Min Zhou, Weibo Cai

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy

外照射放射治疗或靶向放射性核素治疗后肿瘤细胞中 1 型干扰素活化的时间分析

Justin C Jagodinsky, Won Jong Jin, Amber M Bates, Reinier Hernandez, Joseph J Grudzinski, Ian R Marsh, Ishan Chakravarty, Ian S Arthur, Luke M Zangl, Ryan J Brown, Erin J Nystuen, Sarah E Emma, Caroline Kerr, Peter M Carlson, Raghava N Sriramaneni, Jonathan W Engle, Eduardo Aluicio-Sarduy, Todd E Ba